DaVita Inc. (DVA)
DaVita Inc. (DVA) Q1 2025 Earnings Call Transcript
DaVita Inc. (NYSE:DVA ) Q1 2025 Earnings Conference Call May 12, 2025 5:00 PM ET Company Participants Nic Eliason - Group VP, IR Javier Rodriguez - CEO Joel Ackerman - CFO Conference Call Participants Andrew Mok - Barclays Christian Porter - Bank of America Dean Rosales - Wolfe Research Pito Chickering - Deutsche Bank A.J. Rice - UBS Ryan Langston - TD Cowen Operator Good evening.
DaVita HealthCare (DVA) Q1 Earnings and Revenues Beat Estimates
DaVita HealthCare (DVA) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $2.38 per share a year ago.
DaVita First-Quarter 2025 Financial Results: Just the Numbers
Kidney treatment company DaVita (DVA) on Monday afternoon reported first-quarter 2025 financial results. A summary of its key numbers is below.
Can Revenue Cycle Operations Drive DVA Stock Before Q1 Earnings?
Continued strength in revenue cycle operations is likely to have boosted DaVita's top line in the first quarter despite supply challenges weighing on its performance.
DaVita HealthCare (DVA) Outperforms Broader Market: What You Need to Know
DaVita HealthCare (DVA) closed the most recent trading day at $143.96, moving +0.94% from the previous trading session.
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know
DaVita HealthCare (DVA) closed at $140.44 in the latest trading session, marking a -0.78% move from the prior day.
DaVita HealthCare (DVA) Ascends But Remains Behind Market: Some Facts to Note
In the latest trading session, DaVita HealthCare (DVA) closed at $134.97, marking a +1.1% move from the previous day.
Why DaVita Stock Got Rocked This Week
We're in an age when the threat of cyberattacks is real and substantial. Confirming this, veteran healthcare company DaVita (DVA -0.91%) suffered a hacker ambush in recent days, a situation that spooked many investors.
DaVita HealthCare (DVA) Stock Declines While Market Improves: Some Information for Investors
DaVita HealthCare (DVA) concluded the recent trading session at $140.03, signifying a -1.04% move from its prior day's close.
DaVita Says Ransomware Attack Affecting Some Operations
DaVita has been hit with a ransomware attack that has affected some of the kidney-care company's operations.
Dialysis firm DaVita hit by ransomware attack
DaVita said on Monday it had become aware of a ransomware incident that has encrypted some elements of its network, prompting the dialysis firm to implement measures to limit the effect of the breach.
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know
The latest trading day saw DaVita HealthCare (DVA) settling at $151.91, representing a -0.69% change from its previous close.
